Here is a summary of fitness briefs.
Catalent informs in its production plants; Departure of the CFO
Contract drugmaker Catalent Inc warned on Friday that sluggish production in three of its services would affect its fiscal effects for fiscal 2023 and said Chief Financial Officer Thomas Castellano had resigned, sending its shares down more than 20 percent. The company said it encountered “productivity issues” at its gene treatment production facility in Harmans, Maryland, after a slower-than-expected increase in production capacity and that it would generate its third- and fourth-quarter revenue.
FDA Imposes New Safety Warnings for Opioid Painkillers
The U. S. Food and Drug Administration (FDA)The U. S. Food and Drug Administration said Thursday it would require new protective precautions to be added to prescribing data on opioid painkiller labels, adding a warning about increased pain sensitivity. The FDA said knowledge suggests that patients who use opioids for pain relief after surgery have leftover tablets, putting them at risk of addiction and overdose.
Nurses in England reject pay offer and plan new strikes
On Friday, nurses in England rejected an initial offer of a 5% pay rise and laid out plans for more strikes, dealing a blow to Prime Minister Rishi Sunak’s attempts to end the clash and potentially putting pressure on the country’s health services. About 54 percent of nurses who took part in a poll voted to reject the deal, the Royal College of Nursing (RCN) union said, which they did accept. Turnout was 61% of eligible affiliates.
Equatorial Guinea confirms six more from Marburg -WHO
Six more laboratory-confirmed cases of Marburg disease have been reported in Equatorial Guinea, bringing the total number to 15, the World Health Organization (WHO) said on Saturday.
Philips clarifies ventilator numbers after new FDA rebuke
Philips said Friday that 2. 2 million devices it repaired or replaced in a primary ventilator recall are actually in the hands of patients in the United States. The FDA issued an April 13 saying the number of devices the company had replaced was “significantly less” than the 2. 46 million indexed on the company’s website.
No evidence yet to show which animal COVID possibly originated from, says former Chinese CDC chief
There is still no evidence of which animal originated the virus to blame for COVID, the former head of China’s Center for Disease Control and Prevention (CDC) said Friday. George Gao, who spoke at a London summit on pandemic preparedness, at the head of the company when COVID first appeared in Wuhan, China, in late 2019.
Governor of Florida Desantis symptoms ban abortion for 6 weeks
Florida’s Republican governor, Ron DeSantis, signed a bill banning the maximum number of abortions after six weeks, paving the way for drastic abortion relief in the state and southern United States. DeSantis signed the expired bill Thursday night after lawmakers in the Republican-led state House of Representatives approved it by a 70-40 vote. The bill passed the state Senate by a vote of 26 to 13 on April 3.
‘The era is over’ as Beijing subway removes COVID mask rule
Beijing’s subway has eliminated mandatory mask needs for commuters, local media reported Sunday, days after a Chinese fitness expert said the risk of COVID-19 to humans was no longer serious. The replacement of face masks is in line with broader measures across China, which said last week that masks were no longer mandatory on public transport, according to state media.
Netherlands to expand ‘right to die’ to care for terminally ill children
The Netherlands will expand its existing euthanasia regulations to include the option of doctor-assisted death for terminally ill youth aged one to twelve, the Dutch government announced Friday. The new regulations would apply to an estimated five to 10 young people per year. They suffer excruciably from their illness, have no hope of getting better and for whom palliative care cannot provide relief, the government said.
GSK’s antibiotic to treat direct UTIs achieves its goals
British drugmaker GSK said on Saturday its oral antibiotic to treat direct urinary tract infections (UTIs) in adult and adolescent women met the main objectives of late-stage trials. to be on par with or better than nitrofurantoin, the existing popular treatment for the treatment of utiu, the company said.
(With input from agencies. )